AUPH FY 2013 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$948,561-84.6% YoY

Gross Profit

$947,62199.9% margin

Operating Income

-$6M-580.4% margin

Net Income

-$3M-268.4% margin

EPS (Diluted)

$-0.40

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$223,522

Balance Sheet

Total Assets

$23M

Total Liabilities

$10M

Stockholders' Equity

$13M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$948,561	$6M	-84.6%
Gross Profit	$947,621	$6M	-84.5%
Operating Income	-$6M	-$5M	-0.7%
Net Income	-$3M	-$10M	+73.9%